Alcidion Delivers 44% Revenue Surge to $25.5M with Maiden H1 Profit of $1.33M
Alcidion is a leading provider of smart health informatics platforms and solutions, focused on transforming how healthcare is delivered and managed. At its core, Alcidion empowers clinicians with real-time insights, automation, and advanced workflow tools to streamline care delivery across hospitals and health systems. Its flagship platform, Miya Precision, leverages FHIR interoperability, artificial intelligence, and data analytics to unify disparate information sources, offering clinicians actionable guidance that enhances patient safety, operational efficiency, and clinical effectiveness.
The company offers a comprehensive portfolio covering digital patient flow, virtual care, operations centre coordination, specialized and emergency care management, clinical workflow optimization, integrated care records, and modular electronic patient record (EPR) solutions. These tools are designed to simplify administration, reduce bottlenecks, and deliver a safer standard of care—enabling healthcare facilities to address modern challenges such as increasing patient volumes, resource constraints, and demand for greater accountability. Alcidion’s solutions have delivered tangible benefits such as significant reductions in medical errors, shortened clinician admin times, and measurable improvements in patient flow and resource allocation.
Partnering with over 95 leading healthcare organizations across Australia, New Zealand, and the UK—including NHS trusts and major hospitals—Alcidion’s mission is to make healthcare more accessible, personalised, and data-driven. Through continuous innovation and close collaboration with frontline clinicians, Alcidion is driving the future of healthcare—where every point of care is informed, connected, and efficient, ultimately improving outcomes for both patients and providers.
© 2026 StockWire X Pty Ltd. All rights reserved.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.